PA
TNGX icon

Profund Advisors’s Tango Therapeutics TNGX Stock Holding History

Profund Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
41,889
-5,846
-12% -$145K 0.04% 290
2026
Q1 		$999K Sell
47,735
-36,024
-43% -$501K 0.04% 348
2025
Q4 		$742K Buy
83,759
+52,471
+168% +$452K 0.02% 432
2025
Q3 		$263K Buy
+31,288
New +$212K 0.01% 816
2024
Q4 		– Sell
-20,473
Closed -$158K – 1186
2024
Q3 		$158K Buy
20,473
+6,580
+47% +$62.8K 0.01% 1078
2024
Q2 		$119K Sell
13,893
-20,404
-59% -$158K ﹤0.01% 1036
2024
Q1 		$272K Buy
+34,297
New +$368K 0.01% 906

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Profund Advisors's TNGX Position: Q2 2026 in Review

Profund Advisors reduced its Tango Therapeutics (TNGX) stake by 12% in Q2 2026, selling an estimated $145K and leaving 41,889 shares worth $1.31M. The position accounts for 0.04% of the portfolio, ranked #290.

Profund Advisors first reported a position in TNGX in Q1 2024 and has held it in 7 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Profund Advisors held 41,889 shares of Tango Therapeutics worth $1.31M as of Q2 2026.
  • Profund Advisors sold 5,846 Tango Therapeutics shares in Q2 2026, an estimated $145K.
  • Tango Therapeutics made up 0.04% of Profund Advisors's portfolio in Q2 2026, its #290 holding.
  • Profund Advisors first reported a position in Tango Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.